by Agency for Science, Technology and Research (A*STAR), Singapore Graphical abstract. Credit: Theranostics (2022). DOI: 10.7150/thno.72947A recent study discovered a novel therapeutic target named ADAM10 that could be used to treat patients with Diabetic Retinopathy (DR), a condition that leads to blindness induced by prolonged diabetes. Abnormal blood vessel formation in the eyes of diabetic patients is...
